“sanofi” Archives

in
Entry Author Date Location
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Amgen Bests Sanofi-Regeneron In PCSK9 Patent Case, Losers Vow Appeal 03/16/16 New York
Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer 03/03/16 Boston
One Year Post-Launch, Yumanity Lands $45M For Yeasty Discovery 02/10/16 Boston
Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan 01/11/16 Boston
From Ambitions To Markets: Richard Kitney And More Synthetic Bio Views 01/06/16 National
Still Years From Clinic, Navitor Gets $33M And More Pharma Friends 12/18/15 Boston
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Ex-Sanofi CEO Gets $600M to Drug Hunt With Boston Pharma 11/19/15 Boston
Keeping Score, Clinical Watchdogs Push Drugmakers For More Open Data 11/17/15 National
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Idea Behind Warp Drive’s New Cancer Attack Was Hiding In Plain Sight 11/10/15 Boston
Ex-Blueprint Med CEO Resurfaces With $7.5M to Fight Genetic Blindness 11/09/15 Boston
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations 10/29/15 San Francisco
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More 10/08/15 Boston
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard 09/10/15 Boston
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round 09/08/15 Boston
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer 09/01/15 Boston
Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+ 09/01/15 Boston
With FDA OK, Amgen’s Heart Drug Faces Rival (And Health Budgets) 08/27/15 National
Ex-Teva CEO’s Brain Disease Startup, Ovid, Bags $75M From Crossovers 08/11/15 New York
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
Beer Out as Struggling Aegerion Shuffles Leadership Ranks 07/27/15 Boston
FDA OKs Cholesterol Fighter Praluent For More Patients Than Expected 07/24/15 New York
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
Page 2 of 8 « previous page · next page »